BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.63B |
| 2 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$337M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$172M |
| 4 |
PPG Industries
PPG
|
+$132M |
| 5 |
AGN
Allergan plc
AGN
|
+$122M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian National Railway
CNI
|
+$750M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$525M |
| 3 |
Apple
AAPL
|
+$317M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$275M |
| 5 |
McDonald's
MCD
|
+$167M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.55% |
| 2 | Financials | 8.18% |
| 3 | Healthcare | 5.72% |
| 4 | Consumer Discretionary | 5.19% |
| 5 | Communication Services | 4.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZNGA
3301
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $15.1K | ﹤0.01% |
6,620
-10,731
| -62% | -$27.4K |
|
|
HNH
3302
DELISTED
Handy & Harman Holdings Ltd.
HNH
| $15K | ﹤0.01% |
627
+409
| +188% | +$11.4K |
|
3303
Hallador Energy
HNRG
$731M
| $15K | ﹤0.01% |
2,159
+1,253
| +138% | +$9.28K |
|
|
JGW
3304
DELISTED
J G WENTWORTH CO CL A COM STK (DE)
JGW
| $14.8K | ﹤0.01% |
2,995
+1,790
| +149% | +$11.9K |
|
|
XBKS
3305
DELISTED
Xenith Bankshares, Inc. Common Stock
XBKS
| $14.7K | ﹤0.01% |
774
+489
| +172% | +$9.94K |
|
3306
Townsquare Media
TSQ
$104M
| $14.7K | ﹤0.01% |
1,504
+934
| +164% | +$11.3K |
|
|
KEG
3307
DELISTED
KEY ENERGY SERVICES INC
KEG
| $14.6K | ﹤0.01% |
31,071
-5,318
| -15% | -$2.5K |
|
|
FOGO
3308
DELISTED
Fogo de Chao, Inc. Common Stock
FOGO
| $14.6K | ﹤0.01% |
+936
| New | +$18.3K |
|
|
CALA
3309
DELISTED
Calithera Biosciences, Inc
CALA
| $14.6K | ﹤0.01% |
134
+88
| +191% | +$11.4K |
|
3310
Orion
OEC
$360M
| $14.5K | ﹤0.01% |
1,003
+485
| +94% | +$8.34K |
|
3311
Compass Diversified
CODI
$925M
| $14.5K | ﹤0.01% |
898
+577
| +180% | +$9.55K |
|
|
ATCO
3312
DELISTED
Atlas Corp.
ATCO
| $14.4K | ﹤0.01% |
+940
| New | +$16.4K |
|
|
CVRS
3313
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
| $14.4K | ﹤0.01% |
+4,654
| New | +$16.8K |
|
|
RYZ
3314
Ryerson Holding Corp
RYZ
$1.5B
| $14.3K | ﹤0.01% |
2,723
+1,812
| +199% | +$12.9K |
|
3315
Veracyte
VCYT
$3.42B
| $14.2K | ﹤0.01% |
3,035
+1,913
| +170% | +$18.2K |
|
3316
ImmunityBio
IBRX
$8.12B
| $14.2K | ﹤0.01% |
+1,235
| New | +$27K |
|
3317
XBiotech
XBIT
$71M
| $14.1K | ﹤0.01% |
+946
| New | +$16.6K |
|
|
NEFF
3318
DELISTED
Neff Corporation
NEFF
| $14K | ﹤0.01% |
2,512
+1,641
| +188% | +$12.2K |
|
|
AREX
3319
DELISTED
Approach Resources Inc.
AREX
| $14K | ﹤0.01% |
7,471
+4,465
| +149% | +$15K |
|
|
AGRX
3320
DELISTED
Agile Therapeutics
AGRX
| $13.9K | ﹤0.01% |
+1
| New | +$17.8K |
|
|
ATYR
3321
aTyr Pharma
ATYR
$54.7M
| $13.9K | ﹤0.01% |
+97
| New | +$22.1K |
|
|
GI
3322
DELISTED
EndoChoice Holdings, Inc.
GI
| $13.8K | ﹤0.01% |
+1,219
| New | +$19.1K |
|
|
NVTA
3323
DELISTED
Invitae Corporation
NVTA
| $13.8K | ﹤0.01% |
1,911
+1,302
| +214% | +$13.7K |
|
3324
SolarEdge
SEDG
$1.98B
| $13.8K | ﹤0.01% |
+600
| New | +$16.8K |
|
|
SIEN
3325
DELISTED
Sientra, Inc.
SIEN
| $13.6K | ﹤0.01% |
134
+78
| +139% | +$17.7K |
|
Similar funds
BNP Paribas Financial Markets's Q3 2015 Portfolio in Review
As of Q3 2015, BNP Paribas Financial Markets held 3,791 positions worth $39.9B, up 11% from $35.8B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
BNP Paribas Financial Markets deployed $7.43B of net new capital in Q3 2015, opening 248 new positions and adding to 2,429 existing holdings. Its largest new stake was Allergan plc: 397,434 shares worth $108M.
By sector, the portfolio is most concentrated in Technology at 8.6% of assets, down from 10% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $525M trimmed.
- BNP Paribas Financial Markets's largest Q3 2015 buy was Allergan plc: 397,434 shares worth $108M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q3 2015, an estimated $5.63B increase.
- BNP Paribas Financial Markets's biggest Q3 2015 reduction was iShares Russell 2000 ETF, cutting an estimated $525M.
- BNP Paribas Financial Markets fully exited Canadian National Railway in Q3 2015, selling an estimated $750M.
- BNP Paribas Financial Markets's ten largest holdings make up 45% of its $39.9B portfolio in Q3 2015.
- BNP Paribas Financial Markets opened 248 new positions and closed 172 in Q3 2015.
- BNP Paribas Financial Markets's portfolio value rose 11% quarter-over-quarter to $39.9B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2015, filed 13 Nov 2015.